RN7SL652P

Across TCGA pan-cancer cohorts, RN7SL652P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RN7SL652P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL652P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL652P is over-expressed in tumor.

COAD, STAD, and CHOL are the cancer types where RN7SL652P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL652P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.273	.012	4	view →
STAD	Male	II,III,IV	+0.222	.012	4	view →
CHOL	Male	All	+0.323	.021	2	view →
KIRP	Female	II,III,IV	+0.212	.032	2	view →
PRAD	All	All	+0.130	.015	2	view →
LIHC	All	All	+0.084	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RN7SL652P–COAD

Open the COAD breakdown →